Cleared Traditional

K983741 - EVERLAST NEUROSTIMULATION ELECTRODES 2X 2,MODEL # EL2020

K983741 is an FDA 510(k) clearance for EVERLAST NEUROSTIMULATION ELECTRODES 2X 2, manufactured by Axelgaard Mfg. Co., Ltd.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K983741 · Axelgaard Mfg. Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1998
Decision
57d
Days
Class 2
Risk

K983741 is an FDA 510(k) clearance for the EVERLAST NEUROSTIMULATION ELECTRODES 2X 2,MODEL # EL2020. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Axelgaard Mfg. Co., Ltd. (Fallbrook, US). The FDA issued a Cleared decision on December 18, 1998 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Axelgaard Mfg. Co., Ltd. devices

FDA 510(k) Submission Details - K983741

510(k) Number K983741 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 22, 1998
Decision Date December 18, 1998
Days to Decision 57 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
91d faster than avg
Panel avg: 148d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 300
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K983741.
DERMASTIM PLUS, PIGTAILS, FLEXSTIM SUPERFLEX, FLEXSTIM PLUS, CARBONSTIM VERTASTIM, ENDURO
K982096 · Rapid Mfg. Co. · Jun 1999
EEG ELECTRODES MODEL 445 SERIES
K982053 · Class A Ent. · Apr 1999
MSB (ELECTRICAL STIMULATION) ELECTRODES (DISPOSABLE). (TENS/FES/NMES)
K990370 · Msb,Uk · Apr 1999
SLE ELECTRODES AND ACCESSORIES
K980410 · Specialized Laboratory Equipment, Ltd. · Oct 1998
TECA NCS ELECTRODE SYSTEM 2000
K971914 · Medelec, Inc. D.B.A. Teca Corp. · Mar 1998
MSB TENS ELECTRODES (DISPOSABLE)
K980229 · Msb , Ltd. · Feb 1998